Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants

Launched by FRANCISCUS GASTHUIS · Nov 9, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at ways to help preterm infants, born between 30 and 36 weeks of gestation, breathe better and stay healthy during their first 18 months of life. Preterm infants often face more respiratory problems, like infections and wheezing, compared to full-term babies. The researchers believe that by following up with these infants and addressing factors that can be changed—such as exposure to tobacco smoke, pollution, and ensuring they get enough vitamin D—they can reduce these breathing issues.

To participate in this study, infants need to be classified as moderate-late preterm, meaning they were born between 30 weeks and 36 weeks of pregnancy. However, infants with certain serious health conditions, like bronchopulmonary dysplasia (a lung disease), heart problems, or immune system issues, will not be included. Families who join the trial can expect to receive guidance and support aimed at improving their child's lung health and overall well-being. This study is currently recruiting participants, and all families with eligible infants are encouraged to consider joining.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Moderate-late preterm infants (GA 30+0 - 35+6 weeks)
• Exclusion Criteria:
• • bronchopulmonary dysplasia (BPD)
• • congenital diaphragmatic hernia (CHD),
• • congenital pulmonary disorders
• • hemodynamic significant cardiac disease
• • immunodeficiency
• • severe failure to thrive;
• • birth asphyxia with poor neurological outcome
• • syndromic or other severe congenital disorders with decreased life expectancy